Search results
Results From The WOW.Com Content Network
The Clinical Laboratory Improvement Amendments (CLIA) of 1988 are United States federal regulatory standards that apply to all clinical laboratory testing performed on humans in the United States, except clinical trials and basic research.
Fifth Circuit Court of Appeals ruled that plaintiffs suing three manufacturers of thimerosal could bypass the vaccine court and litigate in either state or federal court using the ordinary channels for recovery in tort. [14] This was the first instance where a federal appeals court has held that a suit of this nature may bypass the vaccine court.
Under the NCVIA, the National Vaccine Injury Compensation Program (NVICP) was created to provide a federal no-fault system for compensating vaccine-related injuries or death by establishing a claim procedure involving the United States Court of Federal Claims and special masters. [1] [3]
The Centers for Medicare & Medicaid Services (CMS) is a federal agency within the United States Department of Health and Human Services (HHS) that administers the Medicare program and works in partnership with state governments to administer Medicaid, the Children's Health Insurance Program (CHIP), and health insurance portability standards.
The Federal Courts Improvement Act, 96 Stat. 25., was a law enacted by the United States on April 2, 1982, which established the United States Court of Appeals for the Federal Circuit and the United States Claims Court (later changed to the United States Court of Federal Claims). The statute was intended to promote greater uniformity in certain ...
The court sits from time to time in locations other than Washington, and its judges can and do sit by designation on the benches of other courts of appeals and federal district courts. As of 2016 [update] , Washington and Lee University School of Law's Millhiser Moot Courtroom had been designated as the continuity of operations site for the court.
The feds released a heavily-redacted version of the affidavit that backed up the FBI search of former President Donald Trump's home on August 8.
Association for Molecular Pathology v. Myriad Genetics, Inc., 569 U.S. 576 (2013), was a Supreme Court case, which decided that "a naturally occurring DNA segment is a product of nature and not patent eligible merely because it has been isolated.” [1] However, as a "bizarre conciliatory prize" the Court allowed patenting of complementary DNA, which contains exactly the same protein-coding ...